In HCC-bearing mice which were resistant to PD-1 blockade, dual blockade of TIGIT and PD-1 expanded the effector memory CD8+ T cell population and increased ratio of cytotoxic T cells to Treg in tumors, resulting in suppressed tumor growth and prolonged survival (37). Here, TIGIT is linked to hepatocellular carcinoma.